Company Information

    Pattern Bioscience was founded on April 2016. The company is based in Austin, TX, USA . The number of employees in Pattern Bioscience is less than 50. Pattern bioscience is a privately held in vitro diagnostics company founded in 2016 to help combat the problem of antibiotic resistance.

    Here is how Pattern Bioscience describes itself: "Pattern Bioscience will deliver the fastest ever phenotypic ID/AST"
      If you are the founder or part of the founding team, please tell the world your story


          Funding & investors

          Pattern Bioscience has received 2 rounds of venture funding. The total funding amount is around $25.5M.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors




                  Venture Competitors

                    News

                        Pattern Bioscience - Blog

                          • Building a Great Place to Work

                          • Pattern recently interviewed Cindy Lopez, Director of People and Culture, about building a great place to work—both during these challenging times and beyond. Let’s start by giving everyone a little background info on your professional journey. I started with a degree in accounting, believe it or not, and went from there. My first role in […]The post Building a Great Place to Work appeared first on Pattern Bioscience.
                          • Pattern Raises Additional $9M to Fast-track New Technology for the Fight Against Antibiotic Resistance

                          • Led by Illumina Ventures, the Series B-1 round will accelerate development and validation of transformational bacterial testing technology AUSTIN, Texas, July 14, 2020 – Pattern Bioscience, Inc. today announced $9M in additional funding to accelerate the development and clinical validation of its Digital CultureTM rapid bacterial identification and susceptibility testing (ID/AST) technology. Illumina Ventures led […]The post Pattern Raises Additional $9M to Fast-track New Technology for the Fight Against Antibiotic Resistance appeared first on Pattern Bioscience.
                          • Pattern Secures $13M in Development Funding 

                          • $6.8M CARB-X award plus $6.4M Series B led by Omnimed will help bring new technology to the fight against drug resistance. AUSTIN, Texas, February 4, 2020 – Pattern Bioscience, Inc., formerly operating as Klaris Diagnostics, today announced $13M in funding for the development of its Digital CultureTM technology, a rapid bacterial identification and susceptibility testing (ID/AST) […]The post Pattern Secures $13M in Development Funding  appeared first on Pattern Bioscience.
                          • Klaris Named Finalist in AMR Diagnostic Challenge

                          • Klaris has been selected as a finalist in the AMR Diagnostics Challenge federal prize competition, and will receive $100,000 to further develop its rapid ID/AST technology.  The Challenge is a joint effort between the National Institutes of Health and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) in support of the National […]The post Klaris Named Finalist in AMR Diagnostic Challenge appeared first on Pattern Bioscience.
                          • Klaris Diagnostics Secures $3.75 Million to Help Hospitals Fight Superbugs

                          • Series A Financing Led by Omnimed Capital   Austin, Texas, May 17, 2018 – Klaris Diagnostics, an in vitro diagnostics company focused on simplifying antibiotic selection for drug-resistant infections, today announced the completion of a $3.75 million Series A investment round, led by Omnimed Capital. Proceeds from the round will support additional development of the […]The post Klaris Diagnostics Secures $3.75 Million to Help Hospitals Fight Superbugs appeared first on Pattern Bioscience.

                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *